Evaluation of clinical, laboratory and morphologic prognostic factors in colon cancer

[1]  B. Iacopetta,et al.  Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting , 2007, International Journal of Colorectal Disease.

[2]  T. Nozoe,et al.  Increase in both CEA and CA19‐9 in sera is an independent prognostic indicator in colorectal carcinoma , 2006, Journal of surgical oncology.

[3]  D. Sargent,et al.  Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer. , 2006, Clinical colorectal cancer.

[4]  B. Iacopetta,et al.  Population‐based study of prognostic factors in stage II colonic cancer , 2006, The British journal of surgery.

[5]  R. Labianca,et al.  New strategies in colon cancer adjuvant therapy. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  H. Liang,et al.  Prognostic factors of young patients with colon cancer after surgery. , 2006, World journal of gastroenterology.

[7]  C. Ko,et al.  A 10-Year Outcomes Evaluation of Mucinous and Signet-Ring Cell Carcinoma of the Colon and Rectum , 2005, Diseases of the colon and rectum.

[8]  L. Blomqvist,et al.  Whole-body imaging with MRI or PET/CT: the future for single-modality imaging in oncology? , 2003, JAMA.

[9]  S. Cascinu,et al.  Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough? , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  R. Labianca,et al.  Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  L. Blomqvist.  Preoperative Staging of Colorectal Cancer — Computed Tomography and Magnetic Resonance Imaging , 2003, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[12]  A. Croitoru,et al.  The importance of histopathological and clinical variables in predicting the evolution of colon cancer. , 2002, Romanian journal of gastroenterology.

[13]  N. Shepherd,et al.  Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer , 2002, Gut.

[14]  Y. Panis,et al.  Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence , 2001, Diseases of the colon and rectum.

[15]  S. Wexner,et al.  Dukes B Colorectal Cancer: Distinct Genetic Categories and Clinical Outcome Based on Proximal or Distal Tumor Location , 2001 .

[16]  R. Roetzheim,et al.  Predictors of proximalvs. distal colorectal cancers , 2001, Diseases of the colon and rectum.

[17]  H. Rockette,et al.  Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  N. Renda,et al.  Experimental study of the effect of preoperative 5‐fluorouracil on the integrity of colonic anastomoses , 1998, The British journal of surgery.

[19]  S. Patchett,et al.  Identifying Stage B colorectal cancer patients at high risk of tumor recurrence and death , 1997, Diseases of the colon and rectum.

[20]  Tomoyuki Kato,et al.  Prognostic factors for patients with colon or rectal carcinoma treated with resection only: Five‐year follow‐up report , 1996, Cancer.

[21]  F. Bosman.  Prognostic value of pathological characteristics of colorectal cancer. , 1995, European journal of cancer.

[22]  R. Jakesz,et al.  [Primary (preoperative, neoadjuvant) chemotherapy of colon cancer--a therapeutic alternative?]. , 1994, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[23]  G. Gatta,et al.  Clinical and pathologic prognostic indicators in colorectal cancer. A population‐based study , 1992 .

[24]  K. Shirouzu,et al.  Prognostic factors after potentially curative resection in stage II or III colon cancer. , 2005, The Kurume medical journal.

[25]  K. Sugihara,et al.  Clinical and pathological prognostic indicators with colorectal mucinous carcinomas. , 2004, Hepato-gastroenterology.

[26]  J. Vetto,et al.  Colorectal cancer in young patients: characteristics and outcome. , 1994, The American surgeon.

[27]  J W Arends,et al.  Regression analysis of prognostic factors in colorectal cancer after curative resections , 1988, Diseases of the Colon & Rectum.